Infection Control News

CDC Director Rochelle P. Walensky, MD, has experienced a rebound of COVID-19 symptoms after being treated with Paxlovid, the agency announced Monday.

Common childhood infections have returned following an interruption caused by the COVID-19 pandemic, including respiratory syncytial virus, which has caused a recent surge in the United States. Healio spoke with Mary T. Caserta, MD, a professor of infectious diseases in the department of pediatrics at the University of Rochester Medical Center, about what physicians can expect from RSV.

Influenza reached epidemic levels in Chile months earlier than a typical influenza season, just like in several other Southern Hemisphere countries, researchers reported.

The COVID-19 pandemic has highlighted areas in which the medical community can improve patient care and access to treatment for numerous conditions, including hepatitis D virus.

Disruptions to care caused by the COVID-19 pandemic continued to negatively impact the fight against tuberculosis as cases and deaths have increased for the second year in a row after decades of declines, according to WHO’s 2022 Global TB Report.

WASHINGTON — Neonates with sepsis were exposed to more antibiotics throughout their NICU admissions than controls and were found to have microbiome dysbiosis, researchers reported.

The FDA recently authorized a booster dose of Novavax’s COVID-19 vaccine in adults aged 18 years and older.

WASHINGTON — Using a simulation model, researchers estimated that regular testing and improved engagement in care could add more than 3 years to the life expectancy of HIV-positive Black men who have sex with men.

WASHINGTON — Should ACAM2000 be a first-line vaccine in the current monkeypox outbreak? That was the topic of a pro/con debate during a “clinical controversies” session at IDWeek.

WASHINGTON — A MRSA PCR nasal swab showed promise as a tool for antimicrobial stewardship in a large study of pediatric critical care patients, according to findings presented here at IDWeek.